Insider · CIK 0001643346
Seth Blackley
ceoofficerdirector
Files at EVH (Evolent Health, Inc.). First filing Mar 10, 2025, latest Mar 10, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$498k bought, $0 sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
EVH: Evolent Health, Inc.
EVHOct 9, 2026 · close 4.04
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 61Notable | Evolent Health, Inc. | $498k 55,225 shares | +8% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 1, 2025 | EVH Evolent Health, Inc. | AGrant or award Class A Common Stock | +67,150 | $0.00 | $0 | 829,367 | Jul 3, 2025 |
| Mar 6, 2025 | EVH Evolent Health, Inc. | POpen-market purchase Class A Common Stock | +55,225 | $9.01 | $498k | 762,217 | Mar 10, 2025 |
| Mar 1, 2025 | EVH Evolent Health, Inc. | FTax withholding Class A Common Stock | -28,535 | $8.99 | $257k | 383,389 | Mar 4, 2025 |
| Mar 3, 2025 | EVH Evolent Health, Inc. | AGrant or award Class A Common Stock | +235,025 | $0.00 | $0 | 618,414 | Mar 4, 2025 |
| Mar 3, 2025 | EVH Evolent Health, Inc. | AGrant or award Class A Common Stock | +161,346 | $0.00 | $0 | 779,760 | Mar 4, 2025 |
| Mar 3, 2025 | EVH Evolent Health, Inc. | FTax withholding Class A Common Stock | -72,768 | $8.77 | $638k | 706,992 | Mar 4, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.